Effects of an angiotensin Ⅱ type 1 receptor blocker telmisartan on secretory function of β-cell in db/db mice

顾萍,邵加庆,杜宏,卢斌,王扬天,李洁,王燕燕,王坚

DOI: https://doi.org/10.3969/j.issn.1006-6187.2011.06.014

2011-01-01

Abstract:Objective To investigate whether telmisartan has a protective effect on β-cell function in diabetic state. Methods 8-week-old db/db mice were randomized to telmisartan 5 mg?kg-1?d-1, or placebo group. The age-matched nondiabetic littermates db/m mice were treated with placebo as the controls. After 6 weeks of treatment, intraperitoneal glucose tolerance test and immunohistochemical staining for insulin were performed. Islet perfusion was performed to evaluate kinetics of insulin release by using islet perfusion system. Results Telmisartan provided an improvement of glucose tolerance and greatly rescued islet β-cell mass. Telmisartan treatment also improved first-phase insulin response. Conclusions Telmisartan treatment effectively improves glucose tolerance and β-cell function by significantly restoring first-phase insulin secretion in db/db mice.